Agnirva Space Premier League - Expedition #31254: Exploring New Frontiers with Microfluidics: Lab-on-a-Chip for Space Missions

Space exploration demands innovation, especially when it comes to maintaining astronaut health and safety. The Lab-on-a-Chip Application Development-Portable Test System - Exploration experiment, led by Dr. Jake Maule, focused on enhancing portable diagnostic technology for deep space missions.

This version of the experiment was tailored for exploration-class missions, where returning to Earth or waiting for supplies isn’t an option. The aim was to create a diagnostic tool that could detect biological or chemical threats in real-time aboard a spacecraft or on the surface of another planet.

Building on earlier efforts, this iteration was tested during Expedition 18 on the ISS. The team evaluated how microfluidic chips performed in zero gravity and how effectively astronauts could handle and interpret results. One highlight was testing for microbial contamination, a significant concern in closed habitats.

By combining NASA’s engineering capabilities with Charles River’s biosciences expertise, the project achieved several milestones: confirming fluid flow in microgravity, ensuring chip integrity, and validating detection assays.

Why is this important? On long-duration missions, astronauts need autonomy. If an illness occurs or equipment becomes contaminated, immediate diagnosis can be life-saving. This experiment brought us closer to that reality. Plus, these compact systems are perfect for use on Earth in field hospitals, mobile clinics, and emergency response scenarios.

In essence, this project demonstrated how cutting-edge bioengineering can support the next era of human exploration.

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.